http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100997027-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2008-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100997027-B1 |
| titleOfInvention | Tricyclic compound, preparation method thereof and pharmaceutical composition containing same |
| abstract | The compounds of formula (I) and medicaments using them are disclosed:n n n n n n n n ◆ A represents a 5, 6 or 7 membered (hetero) aromatic or non-aromatic ring,n n n ◆ n and n 'are 0, 1 or 2,n n n ◆ X represents an alkylene chain as defined in the specification,n n n ◆ R 3 represents an aryl or heteroaryl group,n n n ◆ One of the groups R 1 and R 2 is a hydrogen atom and the other represents a group of formula (II) as defined in the specification. |
| priorityDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 314.